Linda Litwin

Linda Litwin

Auto-generated profile, based on publicly available information

Linda Litwin

Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
LLL. Litwin
L. Litwin
JSJ. K. M. Sundholm
J. K. M. Sundholm
KRKristiina Rönö
Kristiina Rönö
SKS. B. Koivusalo
S. B. Koivusalo
JEJ. G. Eriksson
J. G. Eriksson
TST. Sarkola
T. Sarkola

14 August 2018 in Polish Heart Journal
Verified
Journal Article
Closed access
PDF file
MKMateusz T. Knop
Mateusz T. Knop
JBJacek Białkowski
Jacek Białkowski
MSMałgorzata Szkutnik
Małgorzata Szkutnik
RFRoland Fiszer
Roland Fiszer
SSSebastian Smerdziński
Sebastian Smerdziński
LLLinda Litwin
Linda Litwin
Background: Atrial septal defect type II (ASD), according to current standards, is closed percutaneously usually after the child has reached the age of 4-5 years. There are limited data regarding such treatment in smaller infants. Aims: To evaluate feasibility, safety and efficacy of percutaneous ASD closure in children under 3 years of age. Methods: Overall group of 149 children < 3 years with hemodynamically significant ASD, who underwent effective transcatheter ASD closure in one tertiary center between 1999 and 2014 were included. Mean procedural age of treated children was 2,2 years and weight 12,5 kg. In all nitinol wire mesh devices were applied (mostly Amplatzer Septal Occluders). ASD was closed by standard technique (except few cases when left disc of implant was inserted initially into right pulmonary vein to prevent oblique position of the device). Complications related to the procedure were divided into major and minor ones. Results: There were 97 children with a single ASD and 52 with double/multiple ASD. No death, no implant embolization, and one major complications occurred during procedure and in follow-up. ASD was completely closed in all but 8 patients with double/multiple ASD. Right ventricle diameter normalization occurred in all during 1 year follow-up. In majority of the patients in follow-up an acceleration of physical development and resolution of accompanying morbidity was observed. Conclusions: Percutaneous ASD device closure can be performer safely in children below 3 years of age with low risk of complication during and after the procedure. Background: Atrial septal defect type II (ASD), according to current standards, is closed percutaneously usually after the child has reached the age of 4-5 years. There are limited data regarding such treatment in smaller infants. Aims: To evaluate feasibility, safety and efficacy of percutaneous ASD closure in children under 3 years of age. Methods: Overall group of 149 children < 3 years with hemodynamically significant ASD, who underwent effective transcatheter ASD closure in one tertiary center between 1999 and 2014 were included. Mean procedural age of treated children was 2,2 years and weight 12,5 kg. In all nitinol wire mesh devices were applied (mostly Amplatzer Septal Occluders). ASD was closed by standard technique (except few cases when left disc of implant was inserted initially into right pulmonary vein to prevent oblique position of the device). Complications related to the procedure were divided into major and minor ones. Results: There were 97 children with a single ASD and 52 with double/multiple ASD. No death, no implant embolization, and one major complications occurred during procedure and in follow-up. ASD was completely closed in all but 8 patients with double/multiple ASD. Right ventricle diameter normalization occurred in all during 1 year follow-up. In majority of the patients in follow-up an acceleration of physical development and resolution of accompanying morbidity was observed. Conclusions: Percutaneous ASD device closure can be performer safely in children below 3 years of age with low risk of complication during and after the procedure.

28 July 2020 in Acta Diabetologica
Verified
Journal Article
Open access
PDF file
LLLinda Litwin
Linda Litwin
JSJohnny Sundholm
Johnny Sundholm
KRKristiina Rönö
Kristiina Rönö
SKSaila B. Koivusalo
Saila B. Koivusalo
JEJohan Gunnar Eriksson
Johan Gunnar Eriksson
TSTaisto Sarkola
Taisto Sarkola
Aims: We aimed to investigate associations between pre-pregnancy obesity, gestational diabetes (GDM), offspring body composition, and left ventricular diastolic and systolic function in early childhood. Methods: This is an observational study, including 201 mother–child pairs originating from the Finnish Gestational Diabetes Prevention Study (RADIEL; 96 with GDM, 128 with pre-pregnancy obesity) with follow-up from gestation to 6-year postpartum. Follow-up included dyads anthropometrics, body composition, blood pressure, and child left ventricular function with comprehensive echocardiography (conventional and strain imaging). Results: Offspring left ventricular diastolic and systolic function was not associated with gestational glucose concentrations, GDM, or pregravida obesity. Child body fat percentage correlated with maternal pre-pregnancy BMI in the setting of maternal obesity (r = 0.23, P = 0.009). After adjusting for child lean body mass, age, sex, systolic BP, resting HR, maternal lean body mass, pre-gestational BMI, and GDM status, child left atrial volume increased by 0.3 ml (95% CI 0.1, 0.5) for each 1% increase in child body fat percentage. Conclusions: No evidence of foetal cardiac programming related to GDM or maternal pre-pregnancy obesity was observed in early childhood. Maternal pre-pregnancy obesity is associated with early weight gain. Child adiposity in early childhood is independently associated with increased left atrial volume, but its implications for long-term left ventricle diastolic function and cardiovascular health remain unknown.

1 January 2015 in Polish Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
KSKarolina Skalec
Karolina Skalec
LLLinda Litwin
Linda Litwin
KDKatarzyna Drozdz
Katarzyna Drozdz
Paweł GaćPaweł Gać
Paweł Gać
PJPrzemyslaw Jazwiec
Przemyslaw Jazwiec
DJDariusz Janczak
Dariusz Janczak
Primary cardiac lymphoma (PCL) is the very rare disease that is associated with a high mortality rate. A prompt and proper diagnosis may affect the prognosis, and proper treatment may improve life expectancy. This report documents the case of a 74-year-old female with primary cardiac lymphoma....

30 May 2022 in Diabetes & Vascular Disease Research
Verified
Journal Article
Open access
JSJohnny Sundholm
Johnny Sundholm
LLLinda Litwin
Linda Litwin
KRKristiina Rönö
Kristiina Rönö
SKSaila B Koivusalo
Saila B Koivusalo
JEJohan Gunnar Eriksson
Johan Gunnar Eriksson
TSTaisto Sarkola
Taisto Sarkola
Obesity is linked to increased arterial size, carotid intima-media thickness and arterial stiffness. The effects of obesity and body composition on muscular artery intima-media and adventitia thickness has previously not been established. The aim of this study was to explore associations between carotid and muscular artery wall layer thickness with body composition and cardiovascular risk factors in early middle-aged women. This is a cross-sectional study including 199 women aged 40±4 years. Arterial lumen (LD), intima-media (IMT) and adventitia thickness (AT) were measured from carotid, brachial and radial arteries using ultra-high frequency ultrasound (22-71 MHz). Women with obesity had increased IMT in carotid (0.47 vs 0.45 mm), brachial (0.19 vs 0.17 mm) and radial arteries (0.16 vs 0.15 mm) and increased brachial AT (0.14 vs 0.13 mm). In multiple regression models all arterial LD (β-range 0.02-0.03 mm/kg/m2), IMT (β-range 0.91-3.37 µm/kg/m2), AT (β-range 0.73-1.38 µm/kg/m2) were significantly associated with BMI. The IMT of all arteries were significantly associated with systolic blood pressure (β-range 0.36-0.85 µm/mmHg), attenuating the association between IMT and BMI (β-range 0.18-2.24 µm/kg/m2). Obese early middle-aged women have increased arterial intima media thickness and brachial artery adventitia thickness compared to non-obese counterparts. The association between BMI and intima-media thickness is partly mediated through blood pressure levels.

30 March 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
EJEwa Jedrzejczyk-Patej
Ewa Jedrzejczyk-Patej
AWAleksandra Woźniak
Aleksandra Woźniak
LLLinda Litwin
Linda Litwin
ASAlina Skiba-Zdrzałek
Alina Skiba-Zdrzałek
MMMichał Mazurek
Michał Mazurek
Oskar KowalskiOskar Kowalski
Oskar Kowalski
Background: A leadless pacemaker is a new concept in which a miniaturized pacing device is self-contained within the heart. Recently published data show that leadless pacemakers are associated with a decreased risk of major complications when compared with transvenous cardiac pacemakers. This seems to be of particular importance in children and young adults in whom various complications may occur during their lifetime. Case summary: Herein, we report the successful implantation of Micra™ Transcatheter Pacing System in two children: 12-year-old boy and 13-year-old girl, along with a long-term follow-up. The children had indications for pacemaker implantation, however, with an expected low percentage of pacing due to paroxysmal nature of the third-degree atrioventricular block. The implantation procedures were performed in general anaesthesia. There were no complications. During the 2-year follow-up, there were no adverse events and the electrical parameters of the device remained stable. Pacing percentage was below 0.1%. Discussion: Transvenous cardiac pacemakers improve quality of life and reduce mortality but may be associated with various short- and long-term complications, mainly related to the presence of transvenous leads and the pulse generator. Compared with adult patients, the implantation of conventional pacemakers in children is still a challenge, not only because of their smaller size but also due to continuing growth, as well as a higher rate of lead and device-related complications. We demonstrate that the implantation of leadless pacemakers in children is feasible and could be worth considering in certain clinical scenarios, especially when ventricular pacing is required rarely.